| Literature DB >> 30801977 |
Denise Harold1,2, Siobhan Connolly1, Brien P Riley3, Kenneth S Kendler3, Shane E McCarthy4, William R McCombie4, Alex Richards5, Michael J Owen5, Michael C O'Donovan5, James Walters5, Gary Donohoe6, Michael Gill1, Aiden Corvin1, Derek W Morris6.
Abstract
Genome-wide association studies (GWASs) are highly effective at identifying common risk variants for schizophrenia. Rare risk variants are also important contributors to schizophrenia etiology but, with the exception of large copy number variants, are difficult to detect with GWAS. Exome and genome sequencing, which have accelerated the study of rare variants, are expensive so alternative methods are needed to aid detection of rare variants. Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals identified as sharing risk haplotypes to search for rare risk variants in coding regions. We identified 45 rare haplotypes (>1 cM) that were significantly more common in cases than controls. By exome sequencing 105 haplotype carriers, we investigated these haplotypes for functional coding variants that could be tested for association in independent GWAS samples. We identified one rare missense variant in PCNT but did not find statistical support for an association with schizophrenia in a replication analysis. However, IBD mapping can prioritize both individual samples and genomic regions for follow-up analysis but genome rather than exome sequencing may be more effective at detecting risk variants on rare haplotypes.Entities:
Keywords: GWAS; IBD mapping; rare variants
Mesh:
Year: 2019 PMID: 30801977 PMCID: PMC8863274 DOI: 10.1002/ajmg.b.32716
Source DB: PubMed Journal: Am J Med Genet B Neuropsychiatr Genet ISSN: 1552-4841 Impact factor: 3.568